Xomed: Nosing out a Niche in ENT
Executive Summary
Xomed zoomed to the top of the ear, nose, and throat industry, willing to tackle a surgical backwater that bigger competitors overlooked. In the process, it has given the industry a boost, with devices that make ENT procedures both physician and patient friendly. But in growing the market as well as the company, Xomed officials have raised the profile of ENT, risking that larger companies will begin to stake out the market.
You may also be interested in...
Endoscopic Procedures Nose Up in ENT Market
Ear, nose and throat surgery is the oldest surgical specialty in the US, and until recently, its age was all too apparent. Before the mid 1980s, surgeries for sinusitis were performed in much the same way they'd been done since the turn of the century-through incisions in the face. But in the last 20 years, functional endoscopic sinus surgery was introduced, coupled with CT scanning technologies that have improved the diagnosis of sinusitis. Today, according to US Surgical Procedure Volumes, a report recently published by the Medtech Insight division of FDC-Windhover, the majority of these procedures employ endoscopic techniques performed on an outpatient basis. Now, endoscopic access is the platform upon which start-ups are fixing particular problems in sinus surgeries.
Acclarent: Can Balloons Open Sinuses and the ENT Device Market?
Acclarent is developing interventional technology for the sinuses, targeting a clinical specialty unfamiliar with these techniques, in the hope of expanding an under-served device area. But will ENT surgeons welcome the change?
Acclarent: Can Balloons Open Sinuses and the ENT Device Market?
Acclarent is developing interventional technology for the sinuses, targeting a clinical specialty unfamiliar with these techniques, in the hope of expanding an under-served device area. But will ENT surgeons welcome the change?